⚒ Resource: SARS-CoV-2 / COVID-19 Genomic Sequence Variant Visualiser

Mike Honey • 19 January 2024

❦ Mike Honey’s Variant Visualiser (COVID-19 Genomic Sequence Analysis).


The region of ‘Oceania/Australia’ is set by default, as the visualiser was created by Mike Honey, a Data Visualisation and Data Integration specialist in Melbourne, Australia.


➲ Choose your country by clicking on the ‘Continent, Country, Location’ dropdown menu in the top-right-hand corner.


The variant visualiser is free to use, and is automatically updated every time you open the link.


❂


© 2024 Mike Honey.

❦ Screenshot of the Variant Visualiser showing SARS-CoV-2 sub-/variants active in the United Kingdom from 1 Nov 2023 – 9 Jan 2024.

 

➲ Data accessed: 19 Jan 2024.

 

© 2024 Mike Honey.

❦ Screenshot of the Variant Visualiser showing SARS-CoV-2 sub-/variants active in the United Kingdom from 1 Jul 2023 – 13 Sep 2023.

 

➲ Data accessed: 13 Sep 2023.

 

© 2024 Mike Honey. ➲

More... ⚒ Resources

'The Approved List of biological agents'. Advisory Committee on Dangerous Pathogens / UKHSA.

On Biosafety Levels, Hazard Groups, SARS-CoV-2, the UKHSA, Notifiable Organisms and Notifiable Diseases

by United Kingdom Health Security Agency (UKHSA) / Health & Safety Executive (HSE) / Control of Substances Hazardous to Health Regulations (COSHH) / C19.Life • 23 October 2025
The Health and Safety Executive (HSE) has designated SARS-CoV-2, the virus that causes COVID-19, a Hazard Group 3 (HG3) pathogen that can cause severe human disease. The United Kingdom’s Health Security Agency (UKHSA) classifies SARS-CoV-2 as a notifiable organism, and COVID-19 as a notifiable disease (2025).

📖 Guidance for Healthcare Employers and Workers on the use of Fluid Resistant Surgical Masks (FRSM) and respirators (FFP3 etc) to comply with the requirements of COSHH (2002) (England) (Updated 2025)

by The British Occupational Hygiene Society ~ COSHH and Healthcare Respiratory Protection • 20 October 2025
‘FRSMs [Surgical Masks] have never been considered either adequate or suitable equipment for protection against inhalable or respirable risks under COSHH.’

⚒ Resource: LitCovid ~ SARS-CoV-2 / COVID-19 Literature Hub

by National Institutes for Health (NIH) / National Center for Biotechnology Information (NCBI) / U.S. National Library of Medicine (NLM USA) • 18 February 2024
❦ LitCovid is the most comprehensive online resource on SARS-CoV-2 / COVID-19, providing access to 417,800+ relevant articles on PubMed. The library of scientific articles is updated daily, and categorised by different research topics (e.g. transmission), as well as geographic locations. ➲ Date accessed: 18 Feb 2024 . ❂ ❦ Useful Categories ✪ Transmission ➤ Characteristics and modes of SARS-CoV-2 transmission. ✪ Prevention ➤ Prevention, control, response and management strategies. ✪ Long Covid ➤ Post-COVID-19 Conditions/Complications (PCC) / Post-Acute Sequelae of COVID-19 (PASC). ✪ Case Reports ➤ Descriptions of specific patient cases. ✪ Treatments ➤ Treatment strategies, therapeutic procedures, and vaccine development. ✪ Forecasting ➤ Modelling, and estimating the trend of SARS-CoV-2 spread. ❂ ➲ LitCovid Online Library ➤ © 2024 National Institutes for Health (NIH) / National Center for Biotechnology Information (NCBI) / U.S. National Library of Medicine (NLM USA).
Genomic mapping of SARS-CoV-2 / COVID-19 variants and subvariants for 2020, 2021, 2022, 2023, 2024.

⚒ Resource: Genomic Mapping of SARS-CoV-2 / COVID-19 Variants

by NextStrain.org / GISAID.org • 21 January 2024
❦ Genomic epidemiology of SARS-CoV-2 with subsampling focused globally since pandemic start. All data and data visualisation by © 2025 NextStrain.org / GISAID.org .